Bioventix Historical Income Statement

BVXP Stock

2,650 60.00 2.32%

Historical analysis of Bioventix income statement accounts such as Interest Expense of 0.0, Selling General Administrative of 1.3 M or Total Revenue of 8.3 M can show how well Bioventix performed in making a profits. Evaluating Bioventix income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Bioventix's future profits or losses.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Bioventix latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bioventix is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioventix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Bioventix Income Statement Analysis

Bioventix Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Bioventix shareholders. The income statement also shows Bioventix investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Bioventix Income Statement Chart

At this time, Bioventix's Income Tax Expense is comparatively stable compared to the past year. Net Interest Income is likely to gain to about 243.9 K in 2025, whereas Selling General Administrative is likely to drop slightly above 1.3 M in 2025.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Tax Provision

Total Revenue

Total revenue comprises all receipts Bioventix generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Bioventix minus its cost of goods sold. It is profit before Bioventix operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Bioventix. It is also known as Bioventix overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Most accounts from Bioventix's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Bioventix current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioventix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Gross Profit	11.9M	12.6M	14.5M	7.6M
Total Revenue	12.8M	13.6M	15.6M	8.3M

Gross Profit Total Revenue

Bioventix income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Income From Continuing Ops	Tax Provision	Net Interest Income	Interest Income	Selling And Marketing Expenses	Reconciled Depreciation
Depreciation And Amortization		0.49	0.86	0.86	0.86	0.87	0.86	0.85	0.85	0.86	0.88	0.84	0.86	0.28	0.87	0.66	0.88	0.73	0.41	0.41	0.96	0.98
Interest Expense	0.49		0.17	0.23	0.22	0.25	0.22	0.21	0.47	0.21	0.36	0.17	0.22	0.5	0.27	-0.02	0.26	-0.03	-0.15	-0.15	0.5	0.47
Selling General Administrative	0.86	0.17		0.97	0.97	0.98	0.97	0.97	0.84	0.97	0.94	0.99	0.97	0.02	0.95	0.84	0.95	0.95	0.69	0.69	0.87	0.85
Total Revenue	0.86	0.23	0.97		1.0	0.99	1.0	1.0	0.91	1.0	0.97	0.98	1.0	0.11	0.99	0.82	0.99	0.88	0.6	0.6	0.86	0.86
Gross Profit	0.86	0.22	0.97	1.0		0.99	1.0	1.0	0.91	1.0	0.97	0.98	1.0	0.1	0.99	0.82	0.99	0.88	0.61	0.61	0.85	0.86
Other Operating Expenses	0.87	0.25	0.98	0.99	0.99		0.98	0.98	0.91	0.98	0.98	0.99	0.98	0.03	0.97	0.82	0.97	0.89	0.62	0.62	0.87	0.87
Operating Income	0.86	0.22	0.97	1.0	1.0	0.98		1.0	0.91	1.0	0.97	0.97	1.0	0.11	0.99	0.81	0.99	0.87	0.6	0.6	0.85	0.85
Ebit	0.85	0.21	0.97	1.0	1.0	0.98	1.0		0.91	1.0	0.97	0.97	1.0	0.12	0.99	0.81	0.99	0.88	0.6	0.6	0.85	0.85
Research Development	0.85	0.47	0.84	0.91	0.91	0.91	0.91	0.91		0.91	0.96	0.87	0.91	0.24	0.93	0.68	0.93	0.67	0.44	0.44	0.83	0.86
Ebitda	0.86	0.21	0.97	1.0	1.0	0.98	1.0	1.0	0.91		0.97	0.97	1.0	0.12	0.99	0.81	0.99	0.88	0.6	0.6	0.85	0.85
Cost Of Revenue	0.88	0.36	0.94	0.97	0.97	0.98	0.97	0.97	0.96	0.97		0.95	0.97	0.17	0.97	0.77	0.97	0.82	0.57	0.57	0.87	0.88
Total Operating Expenses	0.84	0.17	0.99	0.98	0.98	0.99	0.97	0.97	0.87	0.97	0.95		0.97	-0.07	0.95	0.83	0.95	0.92	0.64	0.64	0.84	0.85
Income Before Tax	0.86	0.22	0.97	1.0	1.0	0.98	1.0	1.0	0.91	1.0	0.97	0.97		0.14	1.0	0.81	0.99	0.87	0.6	0.6	0.85	0.85
Total Other Income Expense Net	0.28	0.5	0.02	0.11	0.1	0.03	0.11	0.12	0.24	0.12	0.17	-0.07	0.14		0.19	-0.11	0.18	-0.13	-0.11	-0.11	0.31	0.22
Net Income	0.87	0.27	0.95	0.99	0.99	0.97	0.99	0.99	0.93	0.99	0.97	0.95	1.0	0.19		0.78	0.99	0.83	0.55	0.55	0.85	0.87
Income Tax Expense	0.66	-0.02	0.84	0.82	0.82	0.82	0.81	0.81	0.68	0.81	0.77	0.83	0.81	-0.11	0.78		0.83	0.88	0.91	0.91	0.72	0.74
Net Income From Continuing Ops	0.88	0.26	0.95	0.99	0.99	0.97	0.99	0.99	0.93	0.99	0.97	0.95	0.99	0.18	0.99	0.83		0.84	0.61	0.61	0.87	0.89
Tax Provision	0.73	-0.03	0.95	0.88	0.88	0.89	0.87	0.88	0.67	0.88	0.82	0.92	0.87	-0.13	0.83	0.88	0.84		0.8	0.8	0.77	0.73
Net Interest Income	0.41	-0.15	0.69	0.6	0.61	0.62	0.6	0.6	0.44	0.6	0.57	0.64	0.6	-0.11	0.55	0.91	0.61	0.8		1.0	0.56	0.5
Interest Income	0.41	-0.15	0.69	0.6	0.61	0.62	0.6	0.6	0.44	0.6	0.57	0.64	0.6	-0.11	0.55	0.91	0.61	0.8	1.0		0.56	0.5
Selling And Marketing Expenses	0.96	0.5	0.87	0.86	0.85	0.87	0.85	0.85	0.83	0.85	0.87	0.84	0.85	0.31	0.85	0.72	0.87	0.77	0.56	0.56		0.97
Reconciled Depreciation	0.98	0.47	0.85	0.86	0.86	0.87	0.85	0.85	0.86	0.85	0.88	0.85	0.85	0.22	0.87	0.74	0.89	0.73	0.5	0.5	0.97

Click cells to compare fundamentals

Bioventix Account Relationship Matchups

Bioventix income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	135.1K	143.4K	129.2K	113.6K	130.7K	84.2K
Selling General Administrative	1.5M	1.6M	1.8M	2.0M	2.3M	1.3M
Total Revenue	10.9M	11.7M	12.8M	13.6M	15.6M	8.3M
Gross Profit	10.0M	10.9M	11.9M	12.6M	14.5M	7.6M
Other Operating Expenses	2.6M	2.6M	2.8M	3.0M	3.5M	2.0M
Operating Income	8.3M	9.2M	10.0M	10.6M	12.2M	6.3M
Ebit	8.1M	9.2M	10.1M	10.6M	12.2M	6.3M
Research Development	1.2M	975.3K	1.2M	999.4K	1.1M	906.5K
Ebitda	8.2M	9.3M	10.2M	10.7M	12.4M	6.3M
Cost Of Revenue	952.6K	853.8K	957.6K	1.0M	1.2M	663.8K
Total Operating Expenses	1.6M	1.7M	1.8M	2.0M	2.3M	1.4M
Income Before Tax	8.1M	9.3M	10.1M	10.6M	12.2M	6.3M
Total Other Income Expense Net	(2.3K)	(17.7K)	75.9K	(23.5K)	(27.1K)	(25.7K)
Net Income Applicable To Common Shares	5.9M	7.2M	6.7M	7.7M	8.8M	4.5M
Net Income	6.7M	7.7M	8.4M	8.1M	9.3M	5.2M
Income Tax Expense	1.4M	1.6M	1.7M	2.5M	2.8M	3.0M
Net Income From Continuing Ops	6.7M	7.7M	8.4M	8.1M	9.3M	6.2M
Tax Provision	1.4M	1.6M	1.8M	2.5M	2.9M	1.5M
Net Interest Income	30.6K	4.5K	101.1K	202.0K	232.3K	243.9K
Interest Income	30.6K	4.8K	101.1K	202.0K	232.3K	243.9K
Selling And Marketing Expenses	1.1M	873.8K	1.2M	1.0M	1.2M	698.7K
Reconciled Depreciation	135.1K	143.4K	129.2K	113.6K	130.7K	112.8K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Bioventix Stock Analysis

When running Bioventix's price analysis, check to measure Bioventix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventix is operating at the current time. Most of Bioventix's value examination focuses on studying past and present price action to predict the probability of Bioventix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventix's price. Additionally, you may evaluate how the addition of Bioventix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC